curaleaf
curaleaf · page 3
- Companies
Curaleaf Launches UK’s First CE-Certified Liquid Medical Cannabis Inhaler
Curaleaf Laboratories has announced the launch of the UK’s first CE-certified liquid medical cannabis inhaler, aiming to address growing patient and clinical demand for a discreet and reliable inhalation method.
- Medical
‘Access to Treatment Is Now a Right, Not a Privilege’: Ukraine Approves First Medical Cannabis Imports in Major Step Toward Access
Ukraine has issued its first medical cannabis import permit, marking a major milestone in its treatment rollout despite war-related regulatory challenges.
- Uncategorized
Portuguese Police Bust Criminal Gang Operating As Medical Cannabis Cultivators
Portuguese cultivators have welcomed moves by the country’s police to crack down on a criminal gang using loopholes in its medical cannabis laws to cultivate and illegally export around £15m of product.
- Companies
Inside the UK’s Largest Medical Cannabis Facility: How Curaleaf Laboratories is Transforming Patient Access
Curaleaf Laboratories, has invested significantly in the UK and its state-of-the-art facility in Sunderland, now the country’s largest medical cannabis processing site, employing around 200 staff.
- Press releases
Curaleaf CEO Boris Jordan Announced as Keynote Speaker for International B2B Day at Mary Jane Berlin 2025
Business of Cannabis and Mary Jane are proud to announce that Boris Jordan, Chairman and CEO of Curaleaf, will be the keynote speaker for the International B2B Day in Berlin on 19 June 2025.
- Events
International Experts Gather to Shape the Future of Cannabis Legislation at the Inaugural Global Cannabis Regulatory Summit
A comprehensive cross-section of the world’s most influential policymakers and global regulatory officials are set to meet with a group of the cannabis industry’s leading voices for an unprecedented inaugural global summit.
- Medical
First Products Registered in Ukraine by Curaleaf Ahead of Medical Cannabis Rollout
The first medical cannabis products have officially been registered in Ukraine, meaning patients should be able to access treatment in the coming weeks.
- Opinion
What’s in Store for the European Cannabis Industry in 2025? (Part 1)
Written by Ben Stevens and Sarah Sinclair. 2024 has been a dramatic year for the global cannabis industry, seeing both historic steps forward and concerning regressions in both attitudes and policy.
- Companies
Billions Wiped of US Cannabis Companies’ Market Value Amid Mixed Financial Performance in Q3
US cannabis companies have endured a significant selloff in the days following the results of the election, seeing $2.6bn wiped off their collective market capitalization.
- Markets & Stocks
Flora Growth Significantly Expands European Foothold, Akanda Sees Spike in Revenues, & More From Argent Biopharma
Akanda Corp [stock_market_widget type=”chart” template=”line” assets=”AKAN” range=”1mo” interval=”1d” price_field=”close” border_width=”3″ tension=”0.5″ line_color=”#5679FF” range_selector=”true” axes=”true” cursor=”true” api=”yahoo-finance”] NASDAQ-listed international medical cannabis operator Akanda Corp has seen its stock drop by double digits this week amid the release of its half-year results.
- Uncategorized
Ohio Adult-Use Sales Get Off to Flying Start, With $11m Revenues Reported in First Week
Since Ohio officially launched adult-use cannabis sales earlier this month, businesses have already reported multi-millions of dollars in revenues.
- Uncategorized
US Cannabis Lobbying Spikes on Rescheduling and Banking Reform Progress
Cannabis companies are ramping up their lobbying efforts in Washington, D.C., spending nearly $4 million in the first half of 2024—an increase from $2.4 million in the same period last year.
